Objectives: Despite advances in resuscitation methods, survival after out-of-hospital cardiac arrest remains low, at least in part, due to postcardiac arrest circulatory and neurologic failure. To elucidate the role of nitric oxide (NO) in the recovery from cardiac arrest and cardiopulmonary resuscitation (CPR), we studied the impact of NO synthase (NOS3)/cGMP signaling on cardiac and neurologic outcomes after cardiac arrest and CPR.
I t is estimated that approximately 500,000 people suffer cardiac arrest each year in the United States. Despite advances in resuscitation methods, including therapeutic hypothermia (1), cardiopulmonary resuscitation (CPR) is all too frequently unsuccessful. Although neurologic injury seems to be the major cause of morbidity and death after cardiac arrest (2) , postcardiac arrest myocardial dysfunction also contributes significantly to mortality (3) . However, molecular mechanisms responsible for myocardial dysfunction after cardiac arrest/CPR remain incompletely understood.
Nitric oxide (NO) is produced from NO synthases (NOS1, NOS2, and NOS3). One of the primary targets of NO is soluble guanylate cyclase (sGC). sGC is a heterodimer, composed of ␣ 1 and ␤ 1 subunits in the myocardium. NO binds to the heme moiety of sGC and stimulates the synthesis of the intracellular second messenger cyclic guanosine monophosphate (cGMP) (4) . NO attenuates ischemiareperfusion (IR) injury in various organs, including heart. For instance, overexpression of NOS3 in endothelial cells (5) or cardiomyocytes (6) attenuates IR in-jury in the heart, whereas NOS3 deficiency has been reported to exacerbate IR-induced myocardial stunning (7) . Although these observations support the protective role of NO/NOS3 in myocardial IR injury, the role of NO on the outcome of cardiac arrest remains incompletely defined, at least in part, due to the complex pathophysiological features of the postcardiac arrest syndrome.
In the current study, we examined the impact of NOS3/cGMP-dependent signaling on myocardial and neurologic function after cardiac arrest/CPR in mouse. We hypothesized that myocardial NOS3 confers protection against cardiac arrest/ CPR-induced myocardial dysfunction via a cGMP-dependent manner. To address this hypothesis, we studied wild-type (WT), NOS3-deficient mice (NOS3 Ϫ/Ϫ ), NOS3 Ϫ/Ϫ mice with cardiomyocyterestricted overexpression of NOS3 (NOS3 Ϫ/Ϫ CSTg), and sGC␣1-deficient mice (sGC␣1 Ϫ/Ϫ ). Here, we report that deficiency of NOS3 or sGC␣1 markedly worsens myocardial function and survival after cardiac arrest in mice.
MATERIALS AND METHODS
Mouse. After approval by the Massachusetts General Hospital Subcommittee on Research Animal Care, we studied 2-to 4-monthold female WT, NOS3 Ϫ/Ϫ , NOS3 Ϫ/Ϫ CSTg, and sGC␣1 Ϫ/Ϫ backcrossed 10 generations onto a C57BL/6 background. Female mice were used based on the model used in a previously published article (8) . NOS3 Ϫ/Ϫ CSTg and sGC␣1 Ϫ/Ϫ were generated as described previously (9 -11) .
Animal Preparation. Mice were anesthetized with 80 g/g of ketamine HCl and 12 g/g xylazine HCl delivered by intraperitoneal injection and mechanically ventilated (FIO 2 ϭ 1.0). Arterial blood pressure and left ventricular function were measured with a Millar conductance pressure-volume catheter (SPR-839, Millar Instruments, Houston, TX) inserted through the right carotid artery as described previously (10) . A saline-filled microcatheter (PE-10, Becton Dickinson, Franklin Lakes, NJ) was inserted into the left jugular vein for fluid administration. Blood pressure and needle-probe electrocardiogram monitoring data were recorded and analyzed with the use of a computer-based data acquisition system.
Murine CPR Model. Cardiac arrest was induced by administration of 0.08 mg/g potassium chloride through the jugular catheter and was confirmed by loss of arterial pressure and asystolic rhythm as described previously (8) . After 9 minutes of cardiac arrest, chest compressions were delivered using a finger at a rate of 340ϳ360 beats per minute. Hypothermia was induced with a cooling blanket to achieve a temperature of 28 Ϯ 0.5°C at the initiation of CPR, and mice were allowed to rewarm thereafter without active warming. Body temperature gradually returned to 30 Ϯ 0.5°C at 60 min after CPR, and there was no difference in body temperature between all genotypes throughout the duration of experiments. Return of spontaneous circulation was defined as sustained systolic arterial pressure Ͼ60 mm Hg (12) . Cardiac function was examined during the first 60 min and 24 hrs after CPR. For the measurements of cardiac function 24 hrs after CPR, mice were anesthetized with intraperitoneal administration of fentanyl 250 g/kg and ketamine 100 mg/kg. Hemodynamic data were analyzed using a software (PVAN version 3.6, Millar Instruments). Mice subjected to sham operation that were not subjected to cardiac arrest were used as controls.
Assessment of Neurologic Function. Neurologic function was assessed at 24 hrs after cardiac arrest and CPR or sham surgery using neurologic function scoring system with modification as reported previously (8) .
Histologic Evaluation. Twenty-four hours after cardiac arrest and CPR or sham surgery, mice were euthanized and brain, heart, and liver were harvested, fixed in 4% formalin in phosphate buffered saline and embedded in paraffin. Brain was cut with microtome in coronal planes, and 6 m-thick sections including the CA1 and CA3 sectors of the hippocampus were used for analysis of caspase-3 activation. For histologic evaluation of the heart and liver, 6 m-thick sections of left ventricle at mid-ventricular level and left lobe were used, respectively.
Quantification of leukocyte recruitment to the heart and liver after cardiac arrest and CPR was performed on paraffin sections stained with anti-CD45 monoclonal antibodies (purified rat anti-mouse CD45, BD Biosciences, San Jose, CA). The number of CD45 ϩ cells was manually counted by an investigator blinded to the genotype or treatment in three serial sections per mouse (n ϭ 3 for shamoperated and n ϭ 3-4 for mice subjected to cardiac arrest and CPR for each genotype). The average number of leukocytes per square millimeter of tissue area was reported.
Cell death was detected in cardiac, hepatic, and brain paraffin sections using the terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) technique (Dead-End Fluorometric TUNEL System, Promega Corporation, Madison, WI), as described previously (13) . Sections were also stained with 4Ј,6-diamidino-2-phenylindole dihydrochloride (Vectashield mounting medium with 4Ј,6diamidino-2-phenylindole dihydrochloride, Vector Laboratories, Burlingame, CA) to quantify total number of cells in the area of interest. TUNEL-positive cells were counted in the middle left ventricular section in a short axis and left lobe of the liver and reported as fraction of the total cell count in the same area. TUNEL-positive neurons were manually counted in the CA1 and CA3 sectors of the hippocampus, and number of TUNEL-positive cells per square millimeters of examined area was reported.
Activation of caspase-3 was assessed by immunohistochemistry in paraffin-embedded brain sections using anticleaved caspase-3 antibody (1:80, polyclonal rabbit anticleaved caspase-3 antibody, Cell Signaling, Danvers, MA) according to the protocol recommended by the manufacturer. Cleaved caspase-3positive neurons were manually counted in the CA1 and CA3 sectors of the hippocampus, and number of cleaved caspase-3-positive neurons per square millimeters of examined area was reported.
Measurement of Gene Expression. Total RNA was extracted from LV tissue using TRIzol reagent (Invitrogen, Carlsbad, CA), and cDNA was synthesized using MMLV-RT (Invitrogen). Intercellular cell adhesion molecule (ICAM)-1, interleukin (IL)-1␤, IL-6, hemoxygenase-1, NOS2, and 18S ribosomal RNA transcript levels were measured by real-time polymerase chain reaction using a Realplex 2 system (Eppendorf, Westbury, NY) and primers for ICAM-1 (5Ј-GTGATGCTCAGGTATCCATCCA-3Ј, 5Ј-CACAGTTCTCAAAGCACAGCG-3Ј), IL-1␤ (5Ј-GCAACTGTTCCTGAACTCAACT-3Ј, 5Ј-ATCTTTTGGGGTCCGTCAACT-3Ј), IL-6 (5Ј-TAGTCCTTCCTACCCCAATTTCC-3Ј, 5Ј-TTGG-TCCTTAGCCACTCCTTC-3Ј), hemoxygenase-1 (5Ј-AAGCCGAGAATGCTGAGTTCA-3Ј, 5Ј-GC-CGTGTAGATATGGTACAAGGA-3Ј), NOS2 (5Ј-ACATCGACCCGTCCACAGTAT-3Ј, 5Ј-CAGA-GGGGTAGGCTTGTCTC-3Ј), and 18S rRNA (5Ј-CGGCTACCACATCCAAGGAA-3Ј, 5Ј-GCT-GGAATTACCGCGGCT-3Ј). Changes in the relative gene expression normalized to levels of 18S rRNA were determined using the relative C T method.
Statistical Analysis. All data are expressed as mean Ϯ SEM. Data were analyzed using analysis of variance (ANOVA) for repeated measures or one or two-way ANOVA with a Holm-Sidak post hoc test. If, during the statistical analysis of our data, the parametric assumption was violated (i.e., normality test failed), one or two-way ANOVA on ranks with a Holm-Sidak post hoc test was used. Difference in survival rate was analyzed by Gehan-Breslow test.
RESULTS
Myocardial NOS3 Attenuates Myocardial Dysfunction After Cardiac Arrest and CPR. The rate of return of spontaneous circulation was similar and Ͼ95% in all genotypes. While the CPR time (in seconds) to return of spontaneous circulation tended to be longer in NOS3 Ϫ/Ϫ (161 Ϯ 14) and sGC␣1 Ϫ/Ϫ (163 Ϯ 10) than in WT (126 Ϯ 7) and NOS3 Ϫ/Ϫ CSTg (143 Ϯ 12), differences between groups were not statistically significant. Baseline cardiac function parameters were similar among the four genotypes (Table 1 and Fig. 1 ). Heart rate was depressed similarly in all genotypes before cardiac arrest possibly due to the effects of anesthesia but recovered to the normal levels within the first hour in all genotypes after CPR except for sGC␣1 Ϫ/Ϫ mice that continued to have lower heart rate ( Fig. 1 ). Parameters of cardiac systolic function, including cardiac output, left ventricular ejection fraction, and maximum rate of left ventricular pressure rise (dP/dt max ) were markedly depressed in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ compared with WT during the first hour after CPR. The relaxation time constant , a load-insensitive measure of diastolic function, was markedly prolonged in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ compared with WT after cardiac arrest. Cardiomyocyte-restricted overexpression of NOS3 prevented the decrement of cardiac function after cardiac arrest in NOS3 Ϫ/Ϫ mice.
Depression of cardiac output persisted in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ at 24 hrs after CPR (Table 1) . Although dP/dt max was reduced in WT, NOS3 Ϫ/Ϫ , and sGC␣1 Ϫ/Ϫ 24 hrs after CPR, the magnitude of decrements of dP/dt max was more marked in sGC␣1 Ϫ/Ϫ compared with other genotypes. Load-insensitive indices of LV systolic function, including end-systolic elastance and preload-recruitable stroke work were depressed in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ but not in WT 24 hrs after CPR. LV diastolic function, assessed by the relaxation time constant , was mark-edly impaired in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ 24 hrs after cardiac arrest. Again, cardiomyocyte-restricted overexpression of NOS3 prevented the depression of LV function in NOS3 Ϫ/Ϫ mice 24 hrs after cardiac arrest (Table 1) .
Taken together, these results suggest that deficiency of NOS3 or sGC␣1 markedly worsen functional recovery of myocardial function after cardiac arrest and CPR. Cardiomyocyte-restricted overexpression of NOS3 rescues myocardial function after cardiac arrest and CPR in NOS3 Ϫ/Ϫ .
NOS3 Deficiency Worsened Neurologic
Function 24 hrs After Cardiac Arrest and CPR. Neurologic function was recovered by 24 hrs after CPR in NOS3 Ϫ/Ϫ CSTg (p ϭ NS compared with sham, Table 1 ). Surviving WT, NOS3 Ϫ/Ϫ , and sGC␣1 Ϫ/Ϫ showed impaired neurologic function 24 hrs after cardiac arrest compared with sham-operated mice of respective genotype (p Ͻ 0.05 vs. sham). Although NOS3 Ϫ/Ϫ exhibited markedly impaired neurologic function compared with WT and NOS3 Ϫ/Ϫ CSTg, sGC␣1 Ϫ/Ϫ tended to have better neurologic score than NOS3 Ϫ/Ϫ (p ϭ 0.058) 24 hrs after cardiac arrest.
NOS3 Deficiency Increased Neutrophil Infiltration in Heart and Liver 24 hrs After Cardiac Arrest. The number of CD45 ϩ cells in the heart and liver did not differ between genotypes after sham surgery. Cardiac arrest and CPR increased the number of CD45 ϩ cells in the heart of WT, NOS3 Ϫ / Ϫ , and sGC␣1 Ϫ/Ϫ , but not in the hearts of NOS3 Ϫ/Ϫ CSTg (Fig. 2) . The magnitude of increase of the CD45 ϩ cells in the heart was greater in NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ compared with WT after CPR. In liver tissues, the number of CD45 ϩ cells increased only in NOS3 Ϫ/Ϫ but not in other genotypes after CPR.
NOS3 Deficiency Aggravated Induction of Inflammatory Cytokines in the Heart After CPR. To further examine the mechanisms responsible for the myocardial dysfunction after CPR, we assessed gene expression of inflammatory cytokines in the heart tissue 24 hrs after cardiac arrest. Cardiac arrest induced ICAM-1, IL-1␤, and IL-6 in WT, NOS3 Ϫ/Ϫ , and sGC␣1 Ϫ/Ϫ but not in NOS3 Ϫ/Ϫ CSTg in the heart (Fig. 3 ). Hemoxygenase-1 was induced by CPR similarly in WT and NOS3 Ϫ/Ϫ but not in sGC␣1 Ϫ/Ϫ or NOS3 Ϫ/Ϫ CSTg 24 hrs after CPR. The magnitude of gene expression of ICAM-1 and IL-6 was greater in NOS3 Ϫ/Ϫ than in WT, whereas cardiac arrest did not induce IL-1␤ and IL-6 in NOS3 Ϫ/Ϫ CSTg. iNOS expression levels were not increased 24 hrs after cardiac arrest in the heart. These observations suggest that NOS3 deficiency promoted cardiac arrest-induced inflammatory cytokine induction in the heart.
Impact of Deficiency of NOS3 or sGC␣1 on Cell Death After Cardiac Arrest. The number of TUNEL positive nuclei increased in the hearts of NOS3 Ϫ/Ϫ and sGC␣1 Ϫ/Ϫ but not in those of WT or NOS3 Ϫ/Ϫ CSTg 24 hrs after CPR (Fig. 4) . Although cardiac arrest and CPR increased the number of TUNEL positive nuclei in the liver of all genotypes, the magnitude of increase was greater in NOS3 Ϫ/Ϫ than in other genotypes (Fig.  4 ). In the CA1 and CA3 region of the hippocampus, the number of TUNEL positive nuclei after cardiac arrest was greater in NOS3 Ϫ/Ϫ than in WT (Fig. 5 ). The number of CA1 and CA3 neurons that stained positive for activated caspase-3 after cardiac arrest was greater in NOS3 Ϫ/Ϫ , sGC␣1 Ϫ/Ϫ , and NOS3 Ϫ/Ϫ CSTg than in WT. Cardiomyocyte-specific overexpression of NOS3 attenuated cardiac arrest-induced cell death and activation of caspase 3 in the CA1 and CA3 regions of the hippocampus in NOS3 Ϫ/Ϫ (Fig. 5) .
NOS3 Deficiency Decreases Survival Rate After Cardiac Arrest. Although 2 of 23 WT died within 24 hrs after CPR, all 15 NOS3 Ϫ/Ϫ CSTg survived for 24 hrs after cardiac arrest and CPR (Fig. 6) . Survival rate at 24 hrs after cardiac arrest was markedly worse in NOS3 Ϫ/Ϫ (9 of 21 died) and sGC␣1 Ϫ/Ϫ (6 of 15 died) than in WT and NOS3 Ϫ/Ϫ CSTg. 
DISCUSSION
The current study revealed that congenital NOS3 deficiency markedly worsens myocardial and neurologic function and survival after cardiac arrest/CPR in mice. Deficiency of sGC␣1 depressed cardiac function and decreased survival after CPR to the similar extent as did NOS3 deficiency. Deficiency of either NOS3 or sGC␣1 was associated with marked inflammation and increased cell death in the heart after cardiac arrest. Although CPR caused cell death in liver in all genotypes, the number of dead cells and accumulated leukocytes in the liver were greater in NOS3 Ϫ/Ϫ than in other genotypes. Similarly, the number of dead hippocampal neurons was greater in NOS3 Ϫ/Ϫ than in WT and NOS3 Ϫ/Ϫ CSTg after CPR. Of note, cardiomyocyterestricted overexpression of NOS3 rescued NOS3 Ϫ/Ϫ mice from myocardial and neurologic dysfunction and death after cardiac arrest. Taken together, these observations suggest that NOS3 prevents postcardiac arrest myocardial dysfunction, at least in part, via sGC-dependent mechanisms, and improves outcome of cardiac arrest/CPR.
The potential impact of NO/NOS on the outcome of cardiac arrest remains incompletely understood. We designed this study to characterize the impact of NOS3 on postcardiac arrest myocardial function by taking advantage of mice with varying levels of myocardial NOS3 expression. NOS3 deficiency markedly decreased cardiac output during the first hour and at 24 hrs after CPR compared with WT. This reduction of cardiac output was primarily due to worsened LV function at both time points. Notably, load-insensitive measures of LV systolic and diastolic function were more severely depressed in NOS3 Ϫ/Ϫ than in WT, suggesting that endogenous levels of NOS3derived NO importantly contributes to the recovery of myocardial function after cardiac arrest. The protective role of NOS3 on postcardiac arrest myocardial function is further supported by our observation that myocardial-restricted overexpression of NOS3 prevented cardiac arrest-induced myocardial dysfunction. Taken together, these observations support the hypothesis that NOS3 protects myocardial function after cardiac arrest.
To elucidate the mechanisms responsible for the protective effects of NOS3 on myocardial function, we examined leukocyte accumulation, cytokine induction, and cell death in the heart tissue 24 hrs after CPR. Depressed cardiac function of NOS3 Ϫ/Ϫ mice was associated with increased leukocyte accumulation, augmented expression of ICAM-1 and IL-6, and increased cell death. Our observations are consistent with the findings of Larmann et al (14) , who demonstrated an important role of ICAM-1 and neutrophil recruitment in the cardiac arrest-induced organ dysfunction. Of note, cardiomyocyte-restricted overexpression of NOS3 largely prevented cardiac arrest-induced leukocyte accumulation, inflammatory cytokine induction, and cell death in the heart. These observations support the protective role of NOS3 in cardiac IR injury induced by cardiac arrest and CPR.
NOS3 deficiency decreased survival at 24 hrs after CPR in the present study. In addition to the depressed myocardial function, the decreased survival in NOS3 Ϫ/Ϫ mice after cardiac arrest was also associated with impaired neurologic function, increased hepatic leukocyte accumulation, and increased cell death in the brain and liver. NOS3 deficiency has been shown to increase leukocyte accumulation and exacerbate hepatic injury after IR (15) . The increased cell death in the hippocampus in NOS3 Ϫ/Ϫ mice after cardiac arrest is consistent with the protective role of NOS3 against cerebral ischemia (16) . The observation that NOS3 deficiency promoted the cardiac arrestinduced caspase 3 activation in the CA1 and CA3 regions suggests that hippocampal cell death was, at least in part, caused by apoptosis. It is of note that NOS3 is more concentrated in CA1 hippocampal pyramidal neurons than in any other brain areas (17) . It is likely that worsened ischemic injury of multiple organs contributed to the decreased survival of NOS3 Ϫ/Ϫ mice after cardiac arrest and CPR.
Interestingly, cardiomyocyte-restricted overexpression of NOS3 in NOS3 Ϫ/Ϫ mice markedly improved neurologic function and survival after cardiac arrest. These beneficial effects of excess NOS3 in the heart were associated with attenuated leukocyte infiltration in the liver and decreased cell death in the liver and brain. It is possible that the protection of cardiac function by overexpressed NOS3 in the heart preserved organ perfusion thereby limiting ischemic end-organ damage and improving survival in NOS3 Ϫ/Ϫ after CPR. Alternatively, it is also conceivable that excess NO produced from cardiomyocytes overexpressing NOS3 is transported to remote tissues as an NO-adduct, where NO protected organ function by anti-inflammatory and antiapoptotic effects (18) .
To elucidate the down-stream mechanisms whereby NOS3 confers protection on myocardial function after cardiac arrest and CPR, we examined impact of sGC deficiency by studying mice deficient for sGC␣1. We found that sGC␣1 Ϫ/Ϫ tended to have worse myocardial systolic function (e.g., dP/dt max , see Table 1 and Fig. 1 ) in the first hour and 24 hrs after CPR than did NOS3 Ϫ/Ϫ . The detrimental impact of sGC␣1 deficiency was associated with increased leukocyte accumulation and cell death in the heart and increased 24 hrs mortality similar to the effects of NOS3 deficiency. Although these observations suggest that protective effects of NOS3 on myocardial function and survival after cardiac arrest are, at least in part, mediated via sGC-dependent mechanisms, they also suggest that sources of NO other than NOS3 and/or non-NOdependent sGC activators (e.g., carbon monoxide) may also confer salutary impact on cardiac function after cardiac arrest.
On the other hand, neurologic dysfunction tended to be less marked in sGC␣1 Ϫ/Ϫ than in NOS3 Ϫ/Ϫ mice. Compared with NOS3 deficiency, deficiency of sGC␣1 tended to cause less leukocyte infiltration in the liver and caspase-3 activation in hippocampal neurons after cardiac arrest. It is possible that sGC␣1 deficiency failed to abolish protective effects of NOS3 in these tissues because another sGC isoform (sGC␣2␤1) is expressed or another sGC␣ subunit (␣2) exist in this knockout mouse. It has been reported that sGC␣1 is the predominant ␣ subunit in most tissues, including the heart, whereas sGC␣2 has much lower expression levels in most tissues, except in the brain where in ␣1 and ␣2 are expressed at similar levels (19) . Alternatively, cGMP-independent NO-dependent mechanisms (i.e., protein S-nitrosylation or antioxidant effects [20] ) may be more important for organ protection in the liver or brain than they are in the heart.
Volatile anesthetic has been shown to mimic cardioprotective effects of ischemic preconditioning. Although impact of ketamine on cardiac IR injury remains controversial, it is possible that ketamine may have affected the results in the current study. Potential influence of anesthetic should be carefully considered when interpreting the data obtained from animal models of cardiac arrest.
In summary, the current study revealed important salutary impact of NOS3/sGC signaling in a murine model of cardiac arrest and CPR. Cardiac NOS3 prevented postcardiac arrest myocardial dysfunction and improved neurologic outcome and survival. Our results with sGC␣1-deficient mice suggest that outcome of CPR may be worse in the situations where sGC is functionally impaired (i.e., oxidized) by increased oxidative stress. Further examination of the downstream mechanisms of the protective effects of NOS3/sGC may allow identification of novel molecular targets in the prevention and treatment of organ dysfunction and death after cardiac arrest.
